Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_assertion wasGeneratedBy ECO_0000203 NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_assertion wasDerivedFrom befree-20150227 NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_assertion SIO_000772 15297186 NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_assertion evidence source_evidence_literature NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.
- NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_assertion description "[The best mechanism of delivery of gene therapy for patients is unclear, however, no severe toxicities were found using an adenovirus-mediated p53 gene in this group heavily pretreated patients with recurrent ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752462.RAcChVxV1cw5Ed_cM-EUZAr3NmF8F_ljxJUdJ0lPxIHgA130_provenance.